SCHEMBL5146263

SCHEMBL5146263

Cc1c2ccc3c1[CH]c1cc-2ccc1-3.[CH]1c2ccccc2-c2ccccc21

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4652256 0.79
SCHEMBL218438 0.76 TSHR (0.34)
SCHEMBL27865902 0.76 ALDH1A1 (0.41)
SCHEMBL2050791 0.76 CA12 (0.47) CA12CA9
SCHEMBL2051706 0.74 MEN1 (0.48) CA12CA9
SCHEMBL1453761 0.73
SCHEMBL2047998 0.71 ELANE (0.48)
SCHEMBL218324 0.71 KDM4E (0.33)
SCHEMBL2969427 0.71 ADORA3 (0.39) CA12CA9
SCHEMBL2965734 0.70 PTGS2 (0.36) CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070135596-A1 Preparation of substituted bridged indenyl and related ligands EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135596-A1 Preparation of substituted bridged indenyl and related ligands SP1, TTL, TTLL12 CA12 682/4885CA9 375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.